• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Expanding the therapeutic frontier: esaxerenone in hypertensive patients with CKD and albuminuria.

作者信息

Kanasaki Keizo

机构信息

Shimane University, Faculty of Medicine, Internal Medicine I, Izumo, Shimane, Japan.

The Center for Integrated Kidney Research and Advance, Faculty of Medicine, Shimane University, Izumo, Japan.

出版信息

Hypertens Res. 2025 Aug 21. doi: 10.1038/s41440-025-02313-w.

DOI:10.1038/s41440-025-02313-w
PMID:40841776
Abstract
摘要

相似文献

1
Expanding the therapeutic frontier: esaxerenone in hypertensive patients with CKD and albuminuria.拓展治疗前沿：依普利酮用于慢性肾脏病合并白蛋白尿的高血压患者
Hypertens Res. 2025 Aug 21. doi: 10.1038/s41440-025-02313-w.
2
Efficacy and safety of esaxerenone in hypertensive patients with chronic kidney disease, with or without type 2 diabetes mellitus: a pooled analysis of five clinical studies.依折麦布在伴或不伴2型糖尿病的慢性肾脏病高血压患者中的疗效与安全性：五项临床研究的汇总分析
Hypertens Res. 2025 Jun 30. doi: 10.1038/s41440-025-02259-z.
3
Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes.依沙克缬沙坦可改善糖尿病高血压患者的血压和代谢参数。
Endocr J. 2025 Aug 1;72(8):947-957. doi: 10.1507/endocrj.EJ24-0639. Epub 2025 May 30.
4
Impairment of platelet mitochondrial respiration in patients with chronic kidney disease with and without diabetes.患有和未患糖尿病的慢性肾病患者血小板线粒体呼吸功能受损。
Mol Cell Biochem. 2025 Apr 12. doi: 10.1007/s11010-025-05280-5.
5
The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD Study.NURTuRE-CKD研究中，原发性肾脏诊断对预后的影响及蛋白尿的不同预测能力。
Am J Nephrol. 2025;56(1):1-12. doi: 10.1159/000541770. Epub 2024 Oct 4.
6
Plasma and Urine Metabolites Associated With Nondiabetic Chronic Kidney Disease: The HELIUS Study.与非糖尿病慢性肾脏病相关的血浆和尿液代谢物：HELIUS研究
Kidney Med. 2025 Apr 17;7(7):101009. doi: 10.1016/j.xkme.2025.101009. eCollection 2025 Jul.
7
Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.原发性醛固酮增多症对肾功能的影响：来自 SPAIN-ALDO 登记研究的结果。
J Hypertens. 2024 Oct 1;42(10):1805-1812. doi: 10.1097/HJH.0000000000003813. Epub 2024 Jul 5.
8
Pentoxifylline for diabetic kidney disease.己酮可可碱用于治疗糖尿病肾病。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD006800. doi: 10.1002/14651858.CD006800.pub2.
9
Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.非甾体类盐皮质激素受体拮抗剂在糖尿病肾病患者中的疗效
Postgrad Med. 2023 Apr;135(3):224-233. doi: 10.1080/00325481.2022.2060598. Epub 2022 Apr 20.
10
HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania.替诺福韦时代的HIV与慢性肾脏病：一项来自坦桑尼亚的前瞻性平行组队列研究
Kidney Med. 2024 Nov 15;7(1):100937. doi: 10.1016/j.xkme.2024.100937. eCollection 2025 Jan.

本文引用的文献

1
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.非奈利酮与恩格列净治疗慢性肾脏病合并2型糖尿病
N Engl J Med. 2025 Aug 7;393(6):533-543. doi: 10.1056/NEJMoa2410659. Epub 2025 Jun 5.
2
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂对老年2型糖尿病患者心血管结局的比较疗效：一项目标试验模拟研究
Cardiovasc Diabetol. 2025 May 6;24(1):194. doi: 10.1186/s12933-025-02753-1.
3
'DKD' as the kidney disease relevant to individuals with diabetes.
“糖尿病肾病”是与糖尿病患者相关的肾脏疾病。
Diabetol Int. 2024 Aug 6;15(4):673-676. doi: 10.1007/s13340-024-00747-0. eCollection 2024 Oct.
4
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes.糖尿病肾病：与糖尿病患者相关的肾脏疾病。
Clin Exp Nephrol. 2024 Dec;28(12):1213-1220. doi: 10.1007/s10157-024-02537-z. Epub 2024 Jul 20.
5
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
6
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
7
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.恩格列净与 2 型糖尿病患者的肾脏疾病进展。
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920. Epub 2016 Jun 14.
8
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.降压药物在糖尿病合并肾脏疾病成人患者中的疗效与安全性比较：网状荟萃分析。
Lancet. 2015 May 23;385(9982):2047-56. doi: 10.1016/S0140-6736(14)62459-4.